GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM
Antifosfolipidnyi sindrom (AFS) – simptomo- kompleks, proyavlyayushchiisya trombozom sosudov razlichnoi lokalizatsii i kalibra pri obyazatel'nom nalichii v krovi antifosfolipidnykh antitel (aFL) [1]. K serologicheskim markeram AFS, soglasno mezhdunarodnym diagnosticheskim kriteriyam, otneseny:...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2011-06-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1297 |
id |
doaj-7cbbddb087a743e8bb6702a344b2d5a0 |
---|---|
record_format |
Article |
spelling |
doaj-7cbbddb087a743e8bb6702a344b2d5a02021-08-02T09:05:42ZrusIMA-PRESS LLCНаучно-практическая ревматология1995-44841995-44922011-06-01495838810.14412/1995-4484-2011-14651237GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOME. V. Ostryakova0N. L. PatrushevaA. P. AleksankinL. I. PatrushevN. V. SeredavkinaE. N. AleksandrovaA. V. VolkovT. M. Reshetnyakkaterina.ostryakova@yandex.ruAntifosfolipidnyi sindrom (AFS) – simptomo- kompleks, proyavlyayushchiisya trombozom sosudov razlichnoi lokalizatsii i kalibra pri obyazatel'nom nalichii v krovi antifosfolipidnykh antitel (aFL) [1]. K serologicheskim markeram AFS, soglasno mezhdunarodnym diagnosticheskim kriteriyam, otneseny: antitela k kardiolipinu (aKL) i/ili volchanochnyi antikoagulyant (VA), i/ili antitela k β2-glikoproteinu 1 (anti-β2-GP 1). V zavisimosti ot pozitivnosti po aFL rekomendovano stratifitsirovat' bol'nykh AFS po sleduyushchim kategoriyam: I – vyyavlenie bolee odnogo laboratornogo markera (v lyuboi kombinatsii); IIa – tol'ko VA; IIb – tol'ko aKL; IIc – tol'ko anti-β2-GP 1 [2]https://rsp.mediar-press.net/rsp/article/view/1297 |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
E. V. Ostryakova N. L. Patrusheva A. P. Aleksankin L. I. Patrushev N. V. Seredavkina E. N. Aleksandrova A. V. Volkov T. M. Reshetnyak |
spellingShingle |
E. V. Ostryakova N. L. Patrusheva A. P. Aleksankin L. I. Patrushev N. V. Seredavkina E. N. Aleksandrova A. V. Volkov T. M. Reshetnyak GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM Научно-практическая ревматология |
author_facet |
E. V. Ostryakova N. L. Patrusheva A. P. Aleksankin L. I. Patrushev N. V. Seredavkina E. N. Aleksandrova A. V. Volkov T. M. Reshetnyak |
author_sort |
E. V. Ostryakova |
title |
GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM |
title_short |
GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM |
title_full |
GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM |
title_fullStr |
GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM |
title_full_unstemmed |
GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM |
title_sort |
gomozigotnaya mutatsiya v gene ingibitora aktivatora plazminogena 1 u patsientov s antifosfolipidnym sindromom |
publisher |
IMA-PRESS LLC |
series |
Научно-практическая ревматология |
issn |
1995-4484 1995-4492 |
publishDate |
2011-06-01 |
description |
Antifosfolipidnyi sindrom (AFS) – simptomo- kompleks, proyavlyayushchiisya trombozom sosudov razlichnoi lokalizatsii i kalibra pri obyazatel'nom nalichii v krovi antifosfolipidnykh antitel (aFL) [1]. K serologicheskim markeram AFS, soglasno mezhdunarodnym diagnosticheskim kriteriyam, otneseny: antitela k kardiolipinu (aKL) i/ili volchanochnyi antikoagulyant (VA), i/ili antitela k β2-glikoproteinu 1 (anti-β2-GP 1). V zavisimosti ot pozitivnosti po aFL rekomendovano stratifitsirovat' bol'nykh AFS po sleduyushchim kategoriyam: I – vyyavlenie bolee odnogo laboratornogo markera (v lyuboi kombinatsii); IIa – tol'ko VA; IIb – tol'ko aKL; IIc – tol'ko anti-β2-GP 1 [2] |
url |
https://rsp.mediar-press.net/rsp/article/view/1297 |
work_keys_str_mv |
AT evostryakova gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT nlpatrusheva gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT apaleksankin gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT lipatrushev gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT nvseredavkina gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT enaleksandrova gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT avvolkov gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom AT tmreshetnyak gomozigotnayamutatsiyavgeneingibitoraaktivatoraplazminogena1upatsientovsantifosfolipidnymsindromom |
_version_ |
1721235981624934400 |